Search - tctmd.com

Displaying 921 - 940 of 2042

Sort: Relevancy | Date

Presentation CHIP Florida 2017

Mitigating Operator Risk in Higher-Risk Coronary Procedures

Presenter: Tanveer Rab

January 21, 2017

Presentation CHIP Florida 2017

Case: 79 year old male- HTN, HLD, IDDM, CKD, h/o CVA w/o major deficits

Presenter: Jonathan Scharfstein

January 20, 2017

Presentation CHIP Florida 2017

Evolution of Left Main Percutaneous Revascularization Advancement to a Standard of Care

Presenter: David E. Kandzari

January 20, 2017

Presentation

Association of Rapid Care Process Implementation With Reperfusion Times Across STEMI Networks

Presenter: Christopher Fordyce

January 18, 2017

Presentation

Culprit Vessel vs Multivessel vs In-Hospital Staged PCI for STEMI and Multivessel Disease

Presenter: M.B. Iqbal

January 09, 2017

Presentation AHA 2016

Arterial Revascularization Trial (ART)

Presenter: David P. Taggart

November 15, 2016

AEGIS-I Trial: The Safety and Tolerability of CSL112

Presentation AHA 2016

The Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Human ApoA-I, After Acute Myocardial Infarction: The ApoA-I Event reducingG in Ischemic Syndromes I Trial (AEGIS-I)

Presenter: Michael Gibson

November 15, 2016

Presentation AHA 2016

FUnctional Testing Underlying REvascularization: The FUTURE trial

Presenter: Gilles Rioufol

November 15, 2016

Presentation Cardiovascular Interventions 2016

It's Not All About the Epicardial Vessel... Pay Attention to the Microvasculature!

Presenter: Bruce Samuels

November 11, 2016

Presentation Cardiovascular Interventions 2016

Unprotected Left Main Stenting

Presenter: Paul S. Teirstein

November 10, 2016

Presentation Cardiovascular Interventions 2016

Physiology As Essential Skill - How to be an expert: Caveats, Shortcuts

Presenter: Nils P. Johnson

November 09, 2016

Presentation Cardiovascular Interventions 2016

PCI for STEMI: Fix the Culprit Lesion, or Fix All of the Lesions

Presenter: James Hermiller

November 08, 2016

Presentation TCT 2016

Case Conclusion: How Did We Treat Our Patient?

Presenter: George D. Dangas, Fabio Felice Tarantino, Massimo Fineschi

November 01, 2016

Presentation TCT 2016

Case Introduction: What Device(s) to Choose in a Patient With NSTE-ACS?

Presenter: George D. Dangas, Fabio Felice Tarantino, Massimo Fineschi

November 01, 2016

Presentation TCT 2016

Case Conclusion: How Did We Treat Our Patient?

Presenter: Roxana Mehran, Ferdinando Varbella, Alberto Menozzi

November 01, 2016

Presentation TCT 2016

Intravenous P2Y12 Receptor Inhibitors Transitioning to a Potent Oral Anti-platelet Agent if PCI Is Performed Is Optimal Treatment in NSTE-ACS

Presenter: Roxana Mehran, Ferdinando Varbella, Dominick J. Angiolillo

November 01, 2016

Presentation TCT 2016

To Pretreat or Not to Pretreat? The DUBIUS Trial

Presenter: Roxana Mehran, Ferdinando Varbella, Giuseppe Tarantini

November 01, 2016

Presentation TCT 2016

Case Introduction: An Elderly Patient With NSTE-ACS

Presenter: Roxana Mehran, Ferdinando Varbella, Alberto Menozzi

November 01, 2016

Presentation TCT 2016

Case Presentation: ACS Intervention in the Emerging BRS Era

Presenter: Bagrat Alekyan, Grzegorz L. Kaluza, Evgeny V. Merkulov

November 01, 2016

Presentation TCT 2016

Delivery System and Therapeutic Challenges and Opportunities in Africa

Presenter: Graham A. Cassel, Harun A Otieno

November 01, 2016

Advertisement

Mitigating Operator Risk in Higher-Risk Coronary Procedures

Case: 79 year old male- HTN, HLD, IDDM, CKD, h/o CVA w/o major deficits

Evolution of Left Main Percutaneous Revascularization Advancement to a Standard of Care

Association of Rapid Care Process Implementation With Reperfusion Times Across STEMI Networks

Culprit Vessel vs Multivessel vs In-Hospital Staged PCI for STEMI and Multivessel Disease

Arterial Revascularization Trial (ART)

The Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Human ApoA-I, After Acute Myocardial Infarction: The ApoA-I Event reducingG in Ischemic Syndromes I Trial (AEGIS-I)

FUnctional Testing Underlying REvascularization: The FUTURE trial

It's Not All About the Epicardial Vessel... Pay Attention to the Microvasculature!

Unprotected Left Main Stenting

Physiology As Essential Skill - How to be an expert: Caveats, Shortcuts

PCI for STEMI: Fix the Culprit Lesion, or Fix All of the Lesions

Case Conclusion: How Did We Treat Our Patient?

Case Introduction: What Device(s) to Choose in a Patient With NSTE-ACS?

Case Conclusion: How Did We Treat Our Patient?

Intravenous P2Y12 Receptor Inhibitors Transitioning to a Potent Oral Anti-platelet Agent if PCI Is Performed Is Optimal Treatment in NSTE-ACS

To Pretreat or Not to Pretreat? The DUBIUS Trial

Case Introduction: An Elderly Patient With NSTE-ACS

Case Presentation: ACS Intervention in the Emerging BRS Era

Delivery System and Therapeutic Challenges and Opportunities in Africa

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content